NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 03 04:00PM ET
2.56
Dollar change
-0.03
Percentage change
-1.16
%
Index- P/E- EPS (ttm)-0.05 Insider Own24.89% Shs Outstand388.51M Perf Week-8.24%
Market Cap1.30B Forward P/E- EPS next Y-0.02 Insider Trans-0.27% Shs Float382.25M Perf Month-17.42%
Enterprise Value- PEG- EPS next Q-0.01 Inst Own21.02% Short Float5.83% Perf Quarter-28.69%
Income-25.11M P/S0.88 EPS this Y36.85% Inst Trans16.17% Short Ratio3.02 Perf Half Y-19.75%
Sales1.49B P/B3.66 EPS next Y67.05% ROA-3.88% Short Interest22.28M Perf YTD-18.73%
Book/sh0.70 P/C- EPS next 5Y- ROE-7.75% 52W High4.87 -47.43% Perf Year113.33%
Cash/sh- P/FCF- EPS past 3/5Y60.49% -237.67% ROIC-7.47% 52W Low1.22 109.84% Perf 3Y13.78%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-3.77% - Gross Margin- Volatility4.90% 4.32% Perf 5Y-76.60%
Dividend TTM- EV/Sales- EPS Y/Y TTM84.64% Oper. Margin-1.64% ATR (14)0.14 Perf 10Y-
Dividend Ex-Date- Quick Ratio- Sales Y/Y TTM-19.54% Profit Margin-1.69% RSI (14)28.88 Recom2.00
Dividend Gr. 3/5Y- - Current Ratio1.54 EPS Q/Q93.40% SMA20-10.52% Beta1.92 Target Price4.69
Payout- Debt/Eq0.00 Sales Q/Q33.45% SMA50-19.33% Rel Volume0.58 Prev Close2.59
Employees570 LT Debt/Eq0.00 EarningsMay 06 AMC SMA200-28.26% Avg Volume7.38M Price2.56
IPOJun 12, 2020 Option/ShortYes / Yes EPS/Sales Surpr.230.81% -0.99% Trades Volume4,314,583 Change-1.16%
Date Action Analyst Rating Change Price Target Change
Dec-17-24Initiated Craig Hallum Buy $6
Oct-07-24Initiated UBS Neutral $4
Feb-02-22Upgrade Cowen Underperform → Market Perform $7 → $3
Feb-02-22Initiated Canaccord Genuity Buy $6
Jan-19-22Initiated SVB Leerink Mkt Perform $3
Jan-10-22Resumed Citigroup Neutral $9 → $3.50
Jan-07-22Downgrade Credit Suisse Neutral → Underperform $9 → $3.50
Sep-10-21Initiated Cowen Underperform $7
Sep-02-21Resumed Citigroup Neutral $10
Jul-12-21Downgrade JP Morgan Neutral → Underweight $9
Jul-03-25 11:35PM
Jul-02-25 11:34AM
Jun-30-25 02:29PM
08:30AM
Jun-27-25 05:23AM
12:34PM Loading…
Jun-23-25 12:34PM
Jun-20-25 11:53AM
Jun-03-25 11:44AM
Jun-02-25 12:22PM
May-28-25 09:40AM
May-27-25 11:17AM
May-19-25 10:08AM
May-15-25 09:40AM
May-12-25 12:00PM
May-07-25 12:28PM
05:55PM Loading…
May-06-25 05:55PM
04:05PM
09:45AM
May-05-25 11:09AM
09:46AM
09:16AM
May-02-25 12:40AM
May-01-25 04:30PM
Apr-29-25 11:29AM
09:00AM
Apr-22-25 06:47PM
05:00PM
Apr-21-25 04:05PM
Apr-08-25 04:05PM
06:46AM
04:05PM Loading…
Apr-07-25 04:05PM
Mar-19-25 04:51PM
05:09AM
Mar-18-25 05:03AM
Mar-03-25 09:00AM
Feb-27-25 04:58PM
04:05PM
Feb-26-25 07:33AM
Feb-24-25 04:05PM
Feb-18-25 04:05PM
Feb-05-25 09:00AM
Feb-03-25 12:01AM
Jan-24-25 06:50AM
Jan-14-25 09:30AM
Jan-13-25 09:00AM
Jan-07-25 12:27PM
09:00AM
Dec-17-24 04:05PM
Nov-20-24 08:45AM
Nov-12-24 09:00AM
Nov-07-24 04:01PM
Nov-06-24 04:05PM
Nov-05-24 07:45AM
Oct-29-24 04:05PM
Oct-23-24 04:05PM
Oct-17-24 09:18PM
Oct-15-24 09:15AM
Oct-10-24 05:03PM
Oct-08-24 06:15AM
Sep-26-24 04:00PM
Sep-03-24 11:54PM
04:05PM
Sep-02-24 12:17PM
Aug-22-24 09:00AM
Aug-21-24 04:05PM
Aug-13-24 07:05PM
Aug-05-24 04:05PM
Jul-24-24 04:05PM
Jul-22-24 04:05PM
Jul-07-24 11:53PM
12:32PM
Jun-26-24 04:15PM
Jun-21-24 01:36PM
Jun-14-24 09:00AM
May-29-24 08:00AM
May-15-24 06:04AM
May-09-24 01:01AM
May-08-24 12:13PM
07:31AM
May-07-24 11:54PM
04:05PM
11:03AM
May-01-24 04:05PM
Apr-30-24 04:15PM
Apr-23-24 04:05PM
Apr-22-24 04:05PM
Apr-04-24 04:30PM
Mar-19-24 09:00AM
Mar-13-24 09:10AM
Mar-12-24 05:33PM
04:05PM
Mar-07-24 04:05PM
Feb-26-24 04:05PM
Feb-16-24 04:30PM
Jan-10-24 08:30AM
06:59AM
Jan-08-24 05:00PM
Dec-21-23 10:54AM
08:00AM
Dec-18-23 04:05PM
Clover Health Investments Corp. is a physician enablement technology company, which engages in the provision of Medicare Advantage plans in the United States. Its strategy is powered by its proprietary software platform, Clover Assistant, which aggregates patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic diseases. The company offers PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. The company was founded by Vivek Garipalli and Andrew Toy on July 17, 2014 and is headquartered in Wilmington, DE.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
JAMIE REYNOSOOfficerJul 03 '25Proposed Sale2.5919,78951,254Jul 03 01:27 PM
Reynoso Jamie L.CEO, Medicare AdvantageJun 17 '25Sale2.8620,45058,4873,196,401Jun 18 05:26 PM
JAMIE REYNOSOOfficerJun 17 '25Proposed Sale2.9220,45059,714Jun 17 04:21 PM
Edwards Carladenise ArmbristerDirectorMar 07 '25Sale3.61200,000722,000273,227Mar 11 04:12 PM
Priest Brady PatrickCEO of Home CareMar 06 '25Sale3.6875,000276,0002,418,151Mar 07 06:11 PM
Soares KarenGeneral Counsel & SecretaryMar 06 '25Sale3.8052,500199,5001,299,663Mar 07 05:59 PM
Edwards Carladenise ArmbristerDirectorMar 07 '25Proposed Sale3.72200,000744,000Mar 07 05:05 PM
Priest Brady PatrickOfficerMar 06 '25Proposed Sale3.6875,000276,269Mar 06 06:32 PM
Soares KarenOfficerMar 05 '25Proposed Sale3.8052,500199,500Mar 06 05:10 PM
Soares KarenOfficerMar 06 '25Proposed Sale3.6875,000276,269Mar 06 05:05 PM
Garipalli VivekDirectorJan 07 '25Option Exercise0.001,670,96503,080,232Jan 10 04:34 PM
Garipalli VivekDirectorAug 09 '24Buy1.88531,700999,5961,409,267Aug 13 04:06 PM